机构:[1]Department of Neurology, XuanWu Hospital of Capital Medical University, Beijing, P. R. China,神经内科首都医科大学宣武医院[2]Department of Neurology, the First Hospital of Tsinghua University, Beijing, P. R. China,[3]School of Medical Sciences, Faculty of Medicine, UNSW Australia, New South Wales, Australia,[4]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, P. R. China,[5]National Clinical Research Center for Geriatric Disorders, Beijing, P. R. China,[6]Beijing Institute of Geriatrics, Beijing, P. R. China,[7]PKU Care Rehabilitation Hospital, Beijing, P. R. China
Pathophysiological changes of Alzheimer's Disease (AD) begin decades before clinical symptoms become apparent, providing an important window for early diagnosis and intervention Prodromal stage of AD, a great opportunity for effective treatment and postponing the disease onset, has drawn extensive attention. The application of different biomarkers including neuroimaging, biochemical substances and genes makes AD-related pathology detectable in vivo and exploring novel biomarkers with relatively non-invasive and low cost has intrigued a wide range of interests. To identify individuals with high risk of conversion to AD and apply the research concept of prodromal AD into clinical practice, the utility of various biomarkers for distinguishing prodromal AD is evaluated in this review. Additionally, clinical management focusing on the stage of prodromal AD is summarized in this review for dementia prevention.
基金:
the National Key Research and Development Program of China (2016YFC1306300),
National Natural Science Foundation of China (Grant No. 31371007, 81430037, 61633018),
Beijing Nature Science Foundation (7161009),
Beijing Municipal Science & Technology Commission (Z131100006813022, Z161100002616020),
Beijing Municipal government (PXM2017_026283_000002),
Fundamental and Clinical Cooperative Research Program of Capital Medical University (16JL-L08).
第一作者机构:[1]Department of Neurology, XuanWu Hospital of Capital Medical University, Beijing, P. R. China,[2]Department of Neurology, the First Hospital of Tsinghua University, Beijing, P. R. China,
通讯作者:
通讯机构:[*1]Department of Neurology, XuanWu Hospital of Capital Medical University, Beijing 100053, China,
推荐引用方式(GB/T 7714):
Can Sheng,Yue Huang,Ying Han.Dissection of prodromal Alzheimer's disease[J].FRONTIERS IN BIOSCIENCE-LANDMARK.2018,23(Landmark 1):1272-1291.doi:10.2741/4643.
APA:
Can Sheng,Yue Huang&Ying Han.(2018).Dissection of prodromal Alzheimer's disease.FRONTIERS IN BIOSCIENCE-LANDMARK,23,(Landmark 1)
MLA:
Can Sheng,et al."Dissection of prodromal Alzheimer's disease".FRONTIERS IN BIOSCIENCE-LANDMARK 23..Landmark 1(2018):1272-1291